Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fonseca, Allex J da
NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents	Completed	3	750	RoW	Active, Placebo	Butantan Institute, Valneva Austria GmbH	Chikungunya	02/23	02/24
AddChemo, NCT05764044: Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer	Recruiting	3	365	RoW	cisplatin, gemcitabine, Follow-up	Hospital do Coracao, University of Sao Paulo	Cervical Cancer, Cervix Cancer, Cervix Neoplasm	12/26	12/26
AVISA, NCT04355338: Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil	Completed	N/A	3520	RoW		Butantan Institute	COVID-19	10/21	10/24